인공 심폐 장치 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Heart-lung Machine Market Summary

The global heart-lung machine market size was estimated at USD 2.24 billion in 2025 and is projected to reach USD 3.67 billion by 2033, growing at a CAGR of 6.36% from 2026 to 2033. The increasing burden of cardiovascular diseases, the rising number of open-heart surgeries, the adoption of technologically advanced perfusion systems, and the expansion of healthcare facilities in both emerging and developed regions are key aspects driving the market's growth.

In October 2025, Cleveland Clinic highlighted advances in ex vivo lung perfusion (EVLP), a perfusion-based system functionally aligned with heart-lung machine technologies, to assess and preserve donor lungs before transplantation.

The growth of heart and lung transplant programs is driving rising demand for advanced perfusion and extracorporeal support technologies, including heart-lung machines and associated consumables. In February 2025, the American Journal of Transplantation reported that U.S. adult heart transplants reached 4,092 in 2023, a 101.1% increase since 2012, with waitlist mortality falling to 8.5 deaths per 100 patient-years. Pediatric heart transplants also rose 36.3%, although the transplant rate declined 14.9%, and 5-year post-transplant survival rates were 80.3% for adults and 84.4% for children.In 2023, adult heart transplant rates varied by patient status, with Status 1 to 6 ranging from the highest urgency (Status 1) to the least urgent (Status 6), based on clinical condition and transplant need.

Collaboration between device manufacturers and hospitals is the prominent driver of growth in the heart-lung machine market, as it reduces the time from prototype to clinical use. Major manufacturers and specialist perfusion companies, such as LivaNova PLC and Getinge AB, conduct targeted clinical trials and regulatory programs in collaboration with cardiac centers to validate new cardiopulmonary bypass and ECMO platforms in real-world settings. Achieving regulatory milestones and generating early clinical data directly support broader procurement and hospital adoption. In December 2025, NHS Wales Shared Services Partnership entered into a service agreement with LivaNova UK Limited for the maintenance of heart-lung machines and autotransfusion systems supporting the Cardiothoracic Directorate at Cardiff & Vale University Health Board, covering the period from September 2025 to August 2026.

Moreover, the industry is undergoing significant change. These systems are essential for open-heart and complex thoracic procedures, while advances in surgical techniques, automation, and patient management are redefining their use. Hospitals and surgical centers are adopting new platforms that enhance clinical outcomes, reduce perfusion times, and minimize blood loss, supporting the shift toward precision-driven and minimally invasive cardiac care. In October 2025, Stanford Medicine expanded its minimally invasive coronary artery bypass grafting (CABG) program, which includes robotic-assisted and MIDCAB procedures, offering patients a faster recovery and reduced pain.

In addition, growing awareness and adoption of advanced cardiopulmonary bypass (CPB) techniques are driving the heart-lung machine market. Hospitals and cardiac centers are increasingly recognizing the benefits of modern CPB, which enables precise control of circulation and oxygenation during complex surgeries. This is prompting procurement of heart-lung machines with improved pumps, oxygenators, and integrated monitoring systems. The trend is particularly pronounced in tertiary and high-volume cardiac centers, which aim to enhance surgical efficiency and patient safety. In July-August 2025, a cross-sectional study in Iran reported high levels of awareness, attitude, and self-care behaviors among 138 post-CABG patients, highlighting that education and targeted nursing interventions significantly improve self-management and recovery outcomes.

Global Heart-Lung Machine Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global heart-lung machine market report based on product, application, end use, and region:

• Product Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
• Capital Equipment
  • Pumps
  • Heater-Cooler Units / Heat Exchange Systems
  • Monitoring Systems
  • Others
• Consumables
  • Cannulas
  • By Product
  • Arterial Cannulas
  • Venous Cannulas
  • Cardioplegia Cannulas
  • Vent Cannulas
  • ECMO Cannulas
  • By Age Group
  • Adult
  • Pediatric
  • Oxygenators
  • By Product
  • Membrane Oxygenators
  • ECMO Oxygenators
  • Pediatric/Neonatal Oxygenators
  • Other Oxygenators
  • By Age Group
  • Adult
  • Pediatric
  • Blood Reservoirs & Filtration Systems
  • Tubing Sets & Circuits
  • Accessories & Consumables
• Application Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
• Coronary Artery Bypass Grafting (CABG)
• Heart Valve Surgeries
• Heart Transplant
• Lung Transplant
• Others
• End Use Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
• Public Healthcare Institutions
• Private Healthcare Institutions
• Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Chile
  • Colombia
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model I)
  • 1.6.2. Unit volume estimation (Model II)
  • 1.6.3. Data collection and sources
    • 1.6.3.1. Secondary data collection
    • 1.6.3.2. Primary market intelligence
      • 1.6.3.2.1. In-Depth Interviews (IDIs)
  • 1.6.4. Analytical framework
    • 1.6.4.1. Step 1: Base Market Identification
    • 1.6.4.2. Step 2: Unit Demand Calculation
  • 1.6.5. Forecasting methodology
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1: Understand market dynamics
  • 1.9.2. Objective 2: Understand market estimates & forecasts
  • 1.9.3. Objective 3: Analyze growth drivers, trends, and unit dynamics for heart lung machine
  • 1.9.4. Objective 4: Understand attributes such as strategy framework & competitive landscape

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. Global Heart-lung Machine Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rise in heart and lung transplantation and advanced heart/lung failure care
    • 3.2.1.2. Technological collaborations and partnerships between device manufacturers and hospitals
    • 3.2.1.3. Rising preference for minimally invasive surgery
    • 3.2.1.4. Growing awareness and adoption of advanced cardiopulmonary bypass techniques
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Operational and procedural hurdles restrict advanced CABG techniques
    • 3.2.2.2. Limited access to trained perfusionists and specialized staff
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Growth in pediatric and neonatal cardiac surgery programs
    • 3.2.3.2. Expansion of ECMO use and its synergy with the heart-lung machine market
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Stringent regulatory and quality compliance standards
    • 3.2.4.2. Import dependency creates operational uncertainty for heart-lung machine adoption
• 3.3. Global Heart Lung Machine: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Force Analysis
  • 3.3.2. PESTLE Analysis
• 3.4. Technological innovations in heart-lung machines materials and cannula design
• 3.5. Case Study Analysis
• 3.6. Healthcare Infrastructure Developments
  • 3.6.1. Case Study: Dominican Republic - A Growing Hub For Medtech Manufacturing In Latin America
• 3.7. Procurement & Distribution Landscape
• 3.8. Recent Product Approvals & Market Entry Updates

Chapter 4. Global Heart-lung Machine Market Segment Analysis, By Product, 2021 - 2033 (USD Million) (Unit Volume)

• 4.1. The chapter will include the following:
  • 4.1.1. Market Value (USD Million), 2021 - 2033
  • 4.1.2. Unit Volume in '000 Units, 2021 - 2033
    • 4.1.2.1. Capital Equipment, Existing Install Base, 2021 - 2033
    • 4.1.2.2. Capital Equipment, New Install Base, 2021 - 2033
    • 4.1.2.3. Consumables Unit Volume, 2021 - 2033
  • 4.1.3. Growth Rates (% CAGR)
  • 4.1.4. Data split by:
    • 4.1.4.1. Global, 5 Regions, and 25 Countries
• 4.2. Definition and Scope
• 4.3. Heart-lung Machine Market Share Analysis, 2025 & 2033
• 4.4. Segment Dashboard
• 4.5. Heart-lung Machine Market By Product Outlook
• 4.6. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
• 4.7. Heart-lung Machine Market Estimates and Forecasts 2021 To 2033 (USD Million)
• 4.8. Heart-lung Machine Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 4.8.1. Capital Equipment
    • 4.8.1.1. Capital Equipment Machine Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.8.1.2. Capital Equipment Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 4.8.1.3. Capital Equipment Market (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
    • 4.8.1.4. Capital Equipment Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
      • 4.8.1.4.1. Pumps
        • 4.8.1.4.1.1. Pumps Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.8.1.5. Pumps Market (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
    • 4.8.1.6. Pumps Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
      • 4.8.1.6.1. Heater-Cooler Units / Heat Exchange Systems
        • 4.8.1.6.1.1. Heater-Cooler Units / Heat Exchange Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.1.6.1.2. Heater-Cooler Units / Heat Exchange Systems Market (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
        • 4.8.1.6.1.3. Heater-Cooler Units / Heat Exchange Systems Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
      • 4.8.1.6.2. Monitoring Systems
        • 4.8.1.6.2.1. Monitoring Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.1.6.2.2. Monitoring Systems Market (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
        • 4.8.1.6.2.3. Monitoring Systems Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
      • 4.8.1.6.3. Others
        • 4.8.1.6.3.1. Others Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.1.6.3.2. Others (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
        • 4.8.1.6.3.3. Others Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
  • 4.8.2. Consumables
    • 4.8.2.1. Consumables Machine Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.8.2.2. Consumables Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.1. Oxygenators
        • 4.8.2.2.1.1. Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.1.2. Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.2. By Product
      • 4.8.2.2.3. Membrane Oxygenators
        • 4.8.2.2.3.1. Membrane Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.3.2. Membrane Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.4. ECMO Oxygenators
        • 4.8.2.2.4.1. ECMO Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.4.2. ECMO Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.5. Pediatric/Neonatal Oxygenators
        • 4.8.2.2.5.1. Pediatric/Neonatal Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.5.2. Pediatric/Neonatal Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.6. Other Oxygenators
        • 4.8.2.2.6.1. Other Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.6.2. Other Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.7. By Age Group
      • 4.8.2.2.8. Adult
        • 4.8.2.2.8.1. Adult Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.8.2. Adult Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.9. Pediatric
        • 4.8.2.2.9.1. Pediatric Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.9.2. Pediatric Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.10. Cannulas
        • 4.8.2.2.10.1. Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.10.2. Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.11. By Product
      • 4.8.2.2.12. Arterial Cannulas
        • 4.8.2.2.12.1. Arterial Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.12.2. Arterial Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.13. Venous Cannulas
        • 4.8.2.2.13.1. Venous Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.13.2. Venous Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.14. Cardioplegia Cannulas
        • 4.8.2.2.14.1. Cardioplegia Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.14.2. Cardioplegia Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.15. Vent Cannulas
        • 4.8.2.2.15.1. Vent Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.15.2. Vent Cannulas Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.16. ECMO Cannulas
        • 4.8.2.2.16.1. ECMO Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.16.2. ECMO Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.17. By Age Group
      • 4.8.2.2.18. Adult
        • 4.8.2.2.18.1. Adult Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.18.2. Adult Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.19. Pediatric
        • 4.8.2.2.19.1. Pediatric Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.19.2. Pediatric Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.20. Blood Reservoirs & Filtration Systems
        • 4.8.2.2.20.1. Blood Reservoirs & Filtration Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.20.2. Blood Reservoirs & Filtration Systems Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.21. Tubing Sets & Circuits
        • 4.8.2.2.21.1. Tubing Sets & Circuits Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.21.2. Tubing Sets & Circuits Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
      • 4.8.2.2.22. Accessories & Consumables
        • 4.8.2.2.22.1. Accessories & Consumables Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.8.2.2.22.2. Accessories & Consumables Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)

Chapter 5. Global Heart-lung Machine Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Definition and Scope
• 5.3. Application Market Share Analysis, 2025 & 2033
• 5.4. Segment Dashboard
• 5.5. Heart-lung Machine Market, By Application Outlook
• 5.6. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
  • 5.6.1. Coronary Artery Bypass Grafting (CABG)
    • 5.6.1.1. Coronary Artery Bypass Grafting (CABG) Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 5.6.2. Heart Valve Surgeries
    • 5.6.2.1. Heart Valve Surgeries Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 5.6.3. Heart Transplant
    • 5.6.3.1. Heart Transplant Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 5.6.4. Lung Transplant
    • 5.6.4.1. Lung Transplant Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 5.6.5. Others
    • 5.6.5.1. Others Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 6. Global Heart-lung Machine Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2025 & 2033
• 6.3. Segment Dashboard
• 6.4. Heart-lung Machine Market, By End Use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
  • 6.5.1. Public Healthcare Institutions
    • 6.5.1.1. Public Healthcare Institutions Market Estimates and Forecasts 2021 To 2033 (USD Million)
  • 6.5.2. Private Healthcare Institutions
    • 6.5.2.1. Private Healthcare Institutions Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 7. Heart-lung Machine Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 7.1. For each country/region, the final report will provide:
  • 7.1.1. Market size & forecast (Revenue in USD Million; Unit Volume in '000 Units)
  • 7.1.2. Growth Rates (% CAGR)
  • 7.1.3. Competitive Scenario
  • 7.1.4. Regulatory & reimbursement landscape
• 7.2. Regional Market Share Analysis, 2025 & 2033
• 7.3. Regional Market Dashboard
• 7.4. Regional Market Snapshot
• 7.5. Heart-lung Machine Market Share by Region, 2025 & 2033:
• 7.6. North America
  • 7.6.1. North America Heart-lung Machine Market, 2021 - 2033 (USD Million)
  • 7.6.2. Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.6.3. U.S.
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory Scenario & reimbursement scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. U.S. Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.6.3.5. U.S. Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.6.4. Canada
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory Scenario & reimbursement scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Canada Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.6.4.5. Canada Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.6.5. Mexico
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory Scenario & reimbursement scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Mexico Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.6.5.5. Mexico Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
• 7.7. Europe
  • 7.7.1. Europe Heart-lung Machine Market, 2021 - 2033 (USD Million)
  • 7.7.2. Europe Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.7.3. UK
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory Scenario & reimbursement scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. UK Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.7.3.5. UK Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.7.4. Germany
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory Scenario & reimbursement scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Germany Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.7.4.5. Germany Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.7.5. France
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory Scenario & reimbursement scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. France Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.7.5.5. France Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.7.6. Italy
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory Scenario & reimbursement scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Italy Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.7.6.5. Italy Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.7.7. Spain
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Regulatory Scenario & reimbursement scenario
    • 7.7.7.3. Competitive Scenario
    • 7.7.7.4. Spain Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.7.7.5. Spain Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.7.8. Norway
    • 7.7.8.1. Key country dynamics
    • 7.7.8.2. Regulatory Scenario & reimbursement scenario
    • 7.7.8.3. Competitive Scenario
    • 7.7.8.4. Norway Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.7.8.5. Norway Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.7.9. Sweden
    • 7.7.9.1. Key country dynamics
    • 7.7.9.2. Regulatory Scenario & reimbursement scenario
    • 7.7.9.3. Competitive Scenario
    • 7.7.9.4. Sweden Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.7.9.5. Sweden Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.7.10. Denmark
    • 7.7.10.1. Key country dynamics
    • 7.7.10.2. Regulatory Scenario & reimbursement scenario
    • 7.7.10.3. Competitive Scenario
    • 7.7.10.4. Denmark Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.7.10.5. Denmark Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
• 7.8. Asia Pacific
  • 7.8.1. Asia Pacific Heart-lung Machine Market, 2021 - 2033 (USD Million)
  • 7.8.2. Asia Pacific Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.8.3. Japan
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory Scenario & reimbursement scenario
    • 7.8.3.3. Competitive Scenario
    • 7.8.3.4. Japan Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.8.3.5. Japan Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.8.4. China
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory Scenario & reimbursement scenario
    • 7.8.4.3. Competitive Scenario
    • 7.8.4.4. China Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.8.4.5. China Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.8.5. India
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Regulatory Scenario & reimbursement scenario
    • 7.8.5.3. Competitive Scenario
    • 7.8.5.4. India Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.8.5.5. India Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.8.6. Australia
    • 7.8.6.1. Key country dynamics
    • 7.8.6.2. Regulatory Scenario & reimbursement scenario
    • 7.8.6.3. Competitive Scenario
    • 7.8.6.4. Australia Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.8.6.5. Australia Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.8.7. South Korea
    • 7.8.7.1. Key country dynamics
    • 7.8.7.2. Regulatory Scenario & reimbursement scenario
    • 7.8.7.3. Competitive Scenario
    • 7.8.7.4. South Korea Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.8.7.5. South Korea Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.8.8. Thailand
    • 7.8.8.1. Key country dynamics
    • 7.8.8.2. Regulatory Scenario & reimbursement scenario
    • 7.8.8.3. Competitive Scenario
    • 7.8.8.4. Thailand Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.8.8.5. Thailand Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
• 7.9. Latin America
  • 7.9.1. Latin America Heart-lung Machine Market, 2021 - 2033 (USD Million)
  • 7.9.2. Latin America Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.9.3. Brazil
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory Scenario & reimbursement scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. Brazil Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.9.3.5. Brazil Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.9.4. Chile
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory Scenario & reimbursement scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Chile Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.9.4.5. Chile Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.9.5. Colombia
    • 7.9.5.1. Key country dynamics
    • 7.9.5.2. Regulatory Scenario & reimbursement scenario
    • 7.9.5.3. Competitive Scenario
    • 7.9.5.4. Colombia Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.9.5.5. Colombia Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.9.6. Argentina
    • 7.9.6.1. Key country dynamics
    • 7.9.6.2. Regulatory Scenario & reimbursement scenario
    • 7.9.6.3. Competitive Scenario
    • 7.9.6.4. Argentina Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.9.6.5. Argentina Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
• 7.10. Middle East and Africa
  • 7.10.1. Middle East and Africa Heart-lung Machine Market, 2021 - 2033 (USD Million)
  • 7.10.2. Middle East and Africa Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.10.3. South Africa
    • 7.10.3.1. Key country dynamics
    • 7.10.3.2. Regulatory Scenario & reimbursement scenario
    • 7.10.3.3. Competitive Scenario
    • 7.10.3.4. South Africa Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.10.3.5. South Africa Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.10.4. Saudi Arabia
    • 7.10.4.1. Key country dynamics
    • 7.10.4.2. Regulatory Scenario & reimbursement scenario
    • 7.10.4.3. Competitive Scenario
    • 7.10.4.4. Saudi Arabia Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.10.4.5. Saudi Arabia Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.10.5. UAE
    • 7.10.5.1. Key country dynamics
    • 7.10.5.2. Regulatory Scenario & reimbursement scenario
    • 7.10.5.3. Competitive Scenario
    • 7.10.5.4. UAE Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.10.5.5. UAE Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 7.10.6. Kuwait
    • 7.10.6.1. Key country dynamics
    • 7.10.6.2. Regulatory Scenario & reimbursement scenario
    • 7.10.6.3. Competitive Scenario
    • 7.10.6.4. Kuwait Heart-lung Machine Market, 2021 - 2033 (USD Million)
    • 7.10.6.5. Kuwait Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization (Key innovators, market leaders, emerging players)
• 8.3. Company Market Position Analysis, 2025
• 8.4. Estimated Company Market Share Analysis, 2024/2025 (%)
• 8.5. Company Profiles
  • 8.5.1. Medtronic
    • 8.5.1.1. Company overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Terumo Corporation
    • 8.5.2.1. Company overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. LivaNova PLC
    • 8.5.3.1. Company overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. Getinge AB
    • 8.5.4.1. Company overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. Braille Biomedica
    • 8.5.5.1. Company overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. Nipro Corporation do Brasil (NIPRO)
    • 8.5.6.1. Company overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. Surge Cardiovascular
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. EUROSETS
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Technowood America Corporation
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Fresenius Medical Care
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. MERA (Senko Medical Instrument Mfg. Co., Ltd.)
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product benchmarking
    • 8.5.11.4. Strategic initiatives